Search for: "Endo Pharmaceutical" Results 181 - 200 of 254
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2011, 11:35 am by Elie Mystal
He is a distinguished professional who built Endo Laboratories into one of the nation’s largest privately held pharmaceutical companies. [read post]
9 Sep 2011, 6:47 am by Ed Wallis
Bloomberg Notes Surge in Claims Bloomberg News has reported that over 500 lawsuits have been filed against transvaginal mesh manufacturers Johnson & Johnson and Endo Pharmaceutical Holdings. [read post]
8 Sep 2011, 9:51 pm
Manufacturers including J&J and Endo Pharmaceuticals Holdings Inc. [read post]
8 Sep 2011, 9:55 am
If accepted by the FDA, manufacturers, such as Johnson & Johnson, Endo Pharmaceuticals Holdings, Inc. and C.R. [read post]
24 Aug 2011, 12:33 am by Marie Louise
USPTO (Patent Docs) US: ALJ Rogers sets procedural schedule in Certain Coenzyme Q10 (337-TA-790) (ITC 337 Law Blog)   Products Actos (Pioglitazone) – Brazil: STJ rules against extension of patent related to Actos (IP tango) Frova (Frovatriptan) – US: Endo Pharmaceuticals files patent infringement complaint against Mylan in response to Para IV certification filing (Patent Docs) Gemzar (Gemcitabine) – US: ALJ Rogers grants motion to terminate investigation in… [read post]
14 Jul 2011, 8:40 pm
(now part of Pennsylvania-based Endo Pharmaceuticals) and Coloplast. [read post]
6 Jul 2011, 2:21 am by Marie Louise
(2) (PatLit) Lidoderm (Lidocaine) – US: Delaware District Court decision in Endo Pharmaceuticals patent case favors Watson (GenericsWeb) Lidoderm (Lidocaine) – US: Endo files patent infringement suit against Watson in response to Para IV challenge (Patent Docs) Lipitor (Atorvastatin) – UK: English Patent Court grants temporary restraining order against Teva on short notice – Pfizer threatens pharmacies with legal action over generic Atorvastatin… [read post]
4 Jul 2011, 9:59 pm by Patent Docs
Endo Pharmaceuticals Inc. v. [read post]
29 Jun 2011, 9:00 am by Lucas A. Ferrara, Esq.
Qualitest is a wholly owned subsidiary of Endo Pharmaceuticals (Nasdaq: ENDP), a U.S. [read post]
27 Jun 2011, 4:22 pm
Last week, Endo Pharmaceuticals and the FDA announced the recall of two lots of Endocet. [read post]
27 Jun 2011, 11:02 am by Mark Zamora
Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV. [read post]
22 Jun 2011, 4:09 am by Marie Louise
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
18 May 2011, 9:20 pm by Patent Docs
The subject matter was controlled-release oxymorphone formulations, assigned to Endo Pharmaceuticals Inc. in three applications: U.S. [read post]
17 May 2011, 10:37 pm
Endo Pharmaceuticals appealed three applications related to time-released opioids. [read post]
17 May 2011, 8:24 am by Dennis Crouch
Background: Endo Pharmaceuticals has three pending patent applications that were all rejected on obviousness grounds and those rejections were affirmed by the BPAI. [read post]
4 May 2011, 7:52 am by Tron Emptage
  Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis   Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs   Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies   Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms   Fentanyl Fentanyl Extended Release Transdermal System Watson   Methadone … [read post]